Falette N S, Fuqua S A, Chamness G C, Cheah M S, Greene G L, McGuire W L
Department of Medicine/Oncology, University of Texas Health Science Center, San Antonio 78284-7884.
Cancer Res. 1990 Jul 1;50(13):3974-8.
DNA methylation is known to be involved in eukaryotic gene control; it may thus exert effects during development and tumorigenesis. We have examined the methylation status of the estrogen receptor (ER) gene in different human tissues. The ER gene was found to be methylated in placental tissues, but normal breast tissues exhibited a different methylation pattern. In addition, specific sites in the hormone-binding domain of the ER gene were observed to be differently methylated in different human breast tumor specimens. We did not detect, however, any association between the ER status of a tumor and ER gene methylation at these sites. Interestingly, a difference in the methylation status between normal and adjacent breast tumor tissues was observed. Thus, DNA methylation may be considered an additional molecular measure of the genetic heterogeneity in breast cancer.
已知DNA甲基化参与真核基因调控;因此它可能在发育和肿瘤发生过程中发挥作用。我们检测了不同人类组织中雌激素受体(ER)基因的甲基化状态。发现ER基因在胎盘组织中发生甲基化,但正常乳腺组织呈现出不同的甲基化模式。此外,在不同的人类乳腺肿瘤标本中,观察到ER基因激素结合域的特定位点甲基化情况不同。然而,我们未检测到肿瘤的ER状态与这些位点的ER基因甲基化之间存在任何关联。有趣的是,观察到正常乳腺组织与相邻乳腺肿瘤组织之间甲基化状态存在差异。因此,DNA甲基化可被视为乳腺癌基因异质性的一种额外分子指标。